Project
Currently, bone marrow and bone fragments containing valuable stem cells are discarded as waste during routine bone operations. The potential of these stem cells lies primarily in their use for
regenerative therapies, such as the treatment of bone fractures.
Our aim is to harvest these stem cells with new instruments and methods and to store them in cross-border biobanks. Thereby, this valuable resource can be made available for therapeutic purposes
or for research into advanced therapies.
Goals
- Development of a cross-border legally compliant (GMP) method for the extraction, storage, use and quality control of bone material
- Development of a GMP compliant cell product
- Foundation of a BONEBANK organisation
- Establishment of a competence atlas in the field of bone stem cells in the German-Danish border region that attracts interregional interest
Register for free at www.lsnxchange.de to find cooperation partners in the German-Danish border region.
After the login, you can find The BONEBANK competence atlas at the start page.
Results
Usage of Stem Cells
BONEBANK creates the preconditions for a diverse field of application of stem cells in the process of bone healing:
- Storage for future use by other research groups and in clinical studies of stem cell therapy
- Collecting for future personal use or for use by immediate family members
- Improving medical products and developing new treatment modalities in the German-Danish border region
- Donation for other patients
Future Usage of Results
Clinicians and hospitals
implement the BONEBANK approach to harvest bone marrow stem cells during routine operations.
Public and private biobank operators
are part of the BONEBANK value chain to store and
market stem cells.
Public researchers
use bone marrow stem cells for research purposes.
Life Science Industry (Medtech, Biotech, Pharma)
purchase bone marrow stem cells for research and
the development of therapies.
Politicians and the general public
understand the potentials of bone marrow stem cells for regenerative medicine and the value of the BONEBANK network for the cross-border region.
